Perfusion MRI of U87 brain tumors in a mouse model

被引:43
|
作者
Sun, YP
Schmidt, NO
Schmidt, K
Doshi, S
Rubin, JB
Mulkern, RV
Carroll, R
Ziu, M
Erkmen, K
Poussaint, TY
Black, P
Albert, M
Burstein, D
Kieran, MW
机构
[1] Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA
[4] Childrens Hosp, Dept Radiol, Boston, MA 02115 USA
[5] Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA
[6] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA
关键词
arterial spin labeling; perfusion MRI; brain tumor in mouse model; antiangiogenesis;
D O I
10.1002/mrm.20029
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Continuous arterial spin labeling (CASL) was used to obtain an index of cerebral blood flow (ICBF) in the normal mouse brain and in an orthotopic mouse model of human U87 high-grade glioma at 8.5 T. Under the assumption of a constant tissue: blood partition coefficient for water in different tissues, the mean ICBF (n = 14) was found to be 50 +/- 9 mL/100g/min for tumor core and 209 +/- 11 mL/100g/min for normal tissue. The apparent T-1 (T-1app) was 2.01 +/- 0.06 sec for tumor core and 1.66 +/- 0.03 sec for normal tissue. The ICBF and the T-1app values were significantly different (P < 0.001) between these two regions. The detailed changes of ICBF and T-1app in the transition from the tumor core through the tumor periphery to surrounding tissue were studied. Immunohistochemistry indicated that tumor vascularity was not uniform, with microvessel density highest in normal brain and the tissue surrounding the tumor and lowest in the tumor core. The large difference in ICBF between the tumor core and normal tissue suggests that this index might be useful for the assessment of the efficacy of antiangiogenic therapy. Magn Reson Med 51:893-899, 2004. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:893 / 899
页数:7
相关论文
共 50 条
  • [21] Aptamer-Driven Toxin Gene Delivery in U87 Model Glioblastoma Cells
    di Leandro, Luana
    Giansanti, Francesco
    Mei, Sabrina
    Ponziani, Sara
    Colasante, Martina
    Ardini, Matteo
    Angelucci, Francesco
    Pitari, Giuseppina
    d'Angelo, Michele
    Cimini, Annamaria
    Fabbrini, Maria Serena
    Ippoliti, Rodolfo
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [22] Expression of Activin A and Follistatin in Glioblastoma and Their Effects on U87 In Vitro
    Zhang, D. F.
    Li, X. G.
    Su, L. J.
    Meng, Q. L.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2010, 38 (04) : 1343 - 1353
  • [23] The impact of bevacizumab on temozolomide concentrations in intracranial U87 gliomas
    Rachel Grossman
    Michelle A. Rudek
    Harry Brastianos
    Patti Zadnik
    Henry Brem
    Betty Tyler
    Jaishri O. Blakeley
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 129 - 139
  • [24] Differentiation of human glioblastoma U87 cells into cholinergic neuron
    Liu, Honghui
    Xia, Jinye
    Wang, Tiansheng
    Li, Wei
    Song, Yexun
    Tan, Guolin
    NEUROSCIENCE LETTERS, 2019, 704 : 1 - 7
  • [25] The impact of bevacizumab on temozolomide concentrations in intracranial U87 gliomas
    Grossman, Rachel
    Rudek, Michelle A.
    Brastianos, Harry
    Zadnik, Patti
    Brem, Henry
    Tyler, Betty
    Blakeley, Jaishri O.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (01) : 129 - 139
  • [26] Photodynamic therapy of human glioma (U87) in the nude rat
    Chopp, M
    Madigan, L
    Dereski, M
    Jiang, F
    Li, Y
    PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1996, 64 (04) : 707 - 711
  • [27] Pc 4 photodynamic therapy of U87 (human glioma) orthotopic tumor in nude rat brain
    Dean, D
    George, JE
    Ahmad, Y
    Wolfe, MS
    Lilge, L
    Morris, RL
    Peterson, A
    Lust, WD
    Totonchi, A
    Varghai, D
    Li, XL
    Hoppel, CL
    Sun, JY
    Oleinick, NL
    PHOTONIC THERAPEUTICS AND DIAGNOSTICS, 2005, 5686 : 526 - 542
  • [28] Trimodal therapy of U87 human glioblastoma tumors in mice using combined radiotherapy, temozolomide and Imatinib/Gleevec
    Abdollahi, A
    Oertel, S
    Niethammer, A
    Combs, SE
    Peschke, P
    Debus, J
    Huber, PE
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S259 - S259
  • [29] Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors
    Weber, M. A.
    Zoubaa, S.
    Schlieter, M.
    Juettler, E.
    Huttner, H. B.
    Geletneky, K.
    Ittrich, C.
    Lichy, M. P.
    Kroll, A.
    Debus, J.
    Giesel, F. L.
    Hartmann, M.
    Essig, M.
    NEUROLOGY, 2006, 66 (12) : 1899 - 1906
  • [30] Inhibitory effects of chemotaxis inhibitory protein of S. aureus (CHIPS) in U87 glioma mouse xenografts
    Boer, Jennifer Carla
    Domanska, Urszula
    de Haas, Carla
    van Strijp, Jos
    Jongeneel, Evelien
    de Vries, Elisabeth
    Den Dunnen, Wilfred
    Walenkamp, Annemiek
    CANCER RESEARCH, 2013, 73 (08)